Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 46 recruiting now full pipeline #122 of 28,707 conditions

Opioid Use: full-pipeline trial registry

46 of 106 indexed Opioid Use trials are currently recruiting.

Corpus placement: #122 of 28,707 conditions by registered trial count.

106 US clinical trials · 46 currently recruiting · #122 of 28,707 conditions by registered trial count

Opioid Use: 106 US clinical trials tracked, 46 recruiting.

Opioid Use is the subject of 106 registered US clinical trials on ClinicalTrials.gov, 46 of them currently open to new participants. 20 are in Phase 3-4 (later-stage) and 14 in Phase 1-2 (earlier-stage). The most active sponsor is Hospital for Special Surgery, New York, running 7 of these trials.

Enrollment posture brief

Registry condition opioid-use

OPEN 46 | RECR 43% | LATE 20 | EARLY 14 | RANK #122 | SPON 7

Nearest open-share peer: Healthy Volunteer (43% recruiting · 113 trials)

Breast Carcinoma58.9%Non-Hodgkin Lymphoma54.2%Cognitive Impairment43.4%Opioid Use (this)43%Crohn's Disease34.9%
Open-enrollment share among volume-matched conditions near Opioid Use

Opioid Use lists 46 open slots (43% of 106 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Opioid Use on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Opioid Use is recruiting above its size-band peers.

    46 of 106 indexed trials (43.4%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Opioid Use trials is spread across many organizations.

    Hospital for Special Surgery, New York accounts for 7 of 106 trials (6.6%). 69 distinct sponsors appear on at least one study for this condition label.

  3. Typical Opioid Use enrolment sits around 144 participants.

    Median target enrolment is 144 among the 106 trials that report a genuine target (sentinel values excluded). 38 of those (35.8%) plan for fewer than 100 participants.

  4. Opioid Use research is mostly interventional.

    95 interventional and 11 observational studies make up this index (89.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 16Phase 28Phase 38Phase 412

Phase Distribution

PhaseTrial count
Phase 1 6
Phase 2 8
Phase 3 8
Phase 4 12

Named interventions

Most-linked intervention names on Opioid Use records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
5 trials
Acetaminophen Drug
3 trials
Gabapentin Drug
2 trials
Normal saline Drug
2 trials
Acetazolamide Drug
2 trials
Ketorolac Drug
2 trials
Ketamine Drug
2 trials
Ibuprofen 600 mg Drug
2 trials

US sites by state

Facility locations filed on Opioid Use trials. A trial with sites in several states counts in each.

New York 20 trials
Pennsylvania 10 trials
Maryland 9 trials
Massachusetts 7 trials
California 7 trials
Missouri 6 trials
Illinois 6 trials
Texas 5 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Opioid Use page

106 registered trials, 46 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Opioid Use condition card totals 106 registered trials; most-linked intervention Placebo; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.